Strata Critical Medical, Inc.SRTAWEarnings & Financial Report
Nasdaq
SRTAW Q3 2025 Key Financial Metrics
Revenue
$49.3M
Gross Profit
$11.6M
Operating Profit
$-5.6M
Net Profit
$57.4M
Gross Margin
23.6%
Operating Margin
-11.4%
Net Margin
116.5%
YoY Growth
-34.2%
EPS
$0.70
Financial Flow
Strata Critical Medical, Inc. Q3 2025 Financial Summary
Strata Critical Medical, Inc. reported revenue of $49.3M for Q3 2025, with a net profit of $57.4M (116.5% margin). Cost of goods sold was $37.7M, operating expenses totaled $17.2M.
Key Financial Metrics
| Total Revenue | $49.3M |
|---|---|
| Net Profit | $57.4M |
| Gross Margin | 23.6% |
| Operating Margin | -11.4% |
| Report Period | Q3 2025 |
Strata Critical Medical, Inc. Annual Revenue by Year
Strata Critical Medical, Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $248.7M).
| Year | Annual Revenue |
|---|---|
| 2024 | $248.7M |
| 2023 | $225.2M |
| 2022 | $146.1M |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $47.5M | $51.5M | $67.9M | $74.9M | $54.4M | $54.3M | $70.8M | $49.3M |
| YoY Growth | 24.5% | 13.8% | 11.4% | 4.8% | 14.5% | 5.4% | 4.2% | -34.2% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $294.9M | $282.8M | $280.3M | $282.9M | $256.7M | $250.6M | $257.9M | $335.1M |
| Liabilities | $60.6M | $46.2M | $50.9M | $49.4M | $34.7M | $30.8M | $34.8M | $52.1M |
| Equity | $234.3M | $236.6M | $229.4M | $233.5M | $221.9M | $219.7M | $223.1M | $283.0M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-9.3M | $-15.6M | $8.4M | $6.4M | $-1.8M | $-246000 | $-3.1M | $-37.3M |